Breast Cancer Trial, Recruiting (NCT06906237)

Breast Cancer Trial, Recruiting NCT06906237 Sponsor: Istituto Oncologico Veneto IRCCS Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06906237 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who had breast-conserving surgery (surgery that removes the cancer while keeping most of the breast) combined with a specific technique using the chest wall tissue, for early to mid-stage invasive breast cancer or a non-invasive type called ductal carcinoma in situ (DCIS)
People whose surgery took place within the last 10 years, between 2015 and 2025
People who are 18 years of age or older
People who have had at least one year of follow-up care after their surgery

Who may not be able to join:

Male patients
People under 18 years of age
People who had traditional breast-conserving surgery or a different type of breast-reshaping surgery that uses tissue movement techniques (confirm with trial site)
People who had a full breast removal (mastectomy)
People who had breast reconstruction using an implant
People whose breast cancer had spread to other parts of the body or could not be fully removed with surgery
People whose medical follow-up records are incomplete or who were lost to follow-up after their surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 3331779209

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06906237

Sponsor: Istituto Oncologico Veneto IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: +39 3331779209

More information: https://clinicaltrials.gov/study/NCT06906237

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who had breast-conserving surgery (surgery that removes the cancer while keeping most of the breast) combined with a specific technique using the chest wall tissue, for early to mid-stage invasive breast cancer or a non-invasive type called ductal carcinoma in situ (DCIS)
People whose surgery took place within the last 10 years, between 2015 and 2025
People who are 18 years of age or older
People who have had at least one year of follow-up care after their surgery

Who may not be able to join:

Male patients
People under 18 years of age
People who had traditional breast-conserving surgery or a different type of breast-reshaping surgery that uses tissue movement techniques (confirm with trial site)
People who had a full breast removal (mastectomy)
People who had breast reconstruction using an implant
People whose breast cancer had spread to other parts of the body or could not be fully removed with surgery
People whose medical follow-up records are incomplete or who were lost to follow-up after their surgery

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istituto Oncologico Veneto IRCCS

Registry

ClinicalTrials.gov

Start date

18 April 2024

Est. completion

1 October 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Margin infiltration rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov